| scholarly article | Q13442814 |
| P2093 | author name string | Toru Kita | |
| Takeshi Kimura | |||
| Koji Hasegawa | |||
| Yoshitaka Iwanaga | |||
| Hitoo Nishi | |||
| Yasuhide Kuwabara | |||
| Koh Ono | |||
| Kazuya Nagao | |||
| Takahiro Horie | |||
| Minako Kinoshita | |||
| Rieko Takanabe | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 315-320 | |
| P577 | publication date | 2009-08-29 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes | |
| P478 | volume | 389 |
| Q34062716 | Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway |
| Q64924418 | Alteration in cardiac PI3K/Akt/mTOR and ERK signaling pathways with the use of growth hormone and swimming, and the roles of miR21 and miR133. |
| Q52846340 | Applications of Extracellular RNAs in Oncology. |
| Q92471654 | Association of single nucleotide polymorphisms of miRNAs involved in the GLUT4 pathway in T2DM in a Chinese population |
| Q37685243 | Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease |
| Q36932534 | Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure |
| Q41830874 | Characterization of Micro-RNA Changes during the Progression of Type 2 Diabetes in Zucker Diabetic Fatty Rats |
| Q60927182 | Characterization of miRNA profiles in the mammary tissue of dairy cattle in response to heat stress |
| Q38948922 | Comparative Analyses of MicroRNA Microarrays during Cardiogenesis: Functional Perspectives. |
| Q55668859 | Deciphering Non-coding RNAs in Cardiovascular Health and Disease. |
| Q37855088 | Diabetes mellitus, a microRNA-related disease? |
| Q37741735 | Diabetic Cardiomyopathy: An Immunometabolic Perspective |
| Q30362092 | Diagnostic approaches for diabetic cardiomyopathy. |
| Q58108734 | Downregulation of miR-33b promotes non-small cell lung cancer cell growth through reprogramming glucose metabolism miR-33b regulates non-small cell lung cancer cell growth |
| Q64929658 | Downregulation of microRNA-1 attenuates glucose-induced apoptosis by regulating the liver X receptor α in cardiomyocytes. |
| Q48175302 | Effect of chronic consumption of pistachios (Pistacia vera L.) on glucose metabolism in pre-diabetics and type 2 diabetics: A systematic review |
| Q33634957 | Effect of differentiation on microRNA expression in bovine skeletal muscle satellite cells by deep sequencing |
| Q33805820 | Emerging Roles for Natural MicroRNA Sponges |
| Q40381796 | Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy |
| Q99555808 | Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma |
| Q59801792 | Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and Obesity |
| Q57028633 | Expressing MicroRNA Sponge Drastically Improves the Insecticidal Activity of Baculovirus via Increasing the Level of Ecdysteroid Hormone in Larvae |
| Q47400069 | Gene expression and gene associations during the development of heart failure with preserved ejection fraction in the Dahl salt sensitive model of hypertension |
| Q58777512 | HIF-1, Metabolism, and Diabetes in the Embryonic and Adult Heart |
| Q35128292 | Identification of microRNAs in the coral Stylophora pistillata |
| Q37228217 | In vivo delivery of miRNAs for cancer therapy: challenges and strategies. |
| Q26865641 | Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes |
| Q48794491 | Involvement of MicroRNAs in Diabetes and Its Complications |
| Q52558432 | Kruppel-Like Factor 15 Is Critical for the Development of Left Ventricular Hypertrophy. |
| Q41640105 | Lack of miR-133a Decreases Contractility of Diabetic Hearts: A Role for Novel Cross Talk Between Tyrosine Aminotransferase and Tyrosine Hydroxylase |
| Q36645680 | Mapping Human Pluripotent-to-Cardiomyocyte Differentiation: Methylomes, Transcriptomes, and Exon DNA Methylation "Memories". |
| Q36173562 | Mechanisms and therapeutic potential of microRNAs in hypertension. |
| Q41233255 | MiR-29b inhibits the growth of glioma via MYCN dependent way |
| Q34306549 | MicroRNA expression signature in human abdominal aortic aneurysms |
| Q30500389 | MicroRNA miR-133b is essential for functional recovery after spinal cord injury in adult zebrafish |
| Q39189133 | MicroRNA regulation and analytical methods in cancer cell metabolism |
| Q34070117 | MicroRNA regulatory networks in cardiovascular development |
| Q34139023 | MicroRNA sponges: progress and possibilities |
| Q39189781 | MicroRNA-133 mediates cardiac diseases: Mechanisms and clinical implications |
| Q35070980 | MicroRNA-494, upregulated by tumor necrosis factor-α, desensitizes insulin effect in C2C12 muscle cells |
| Q34927574 | MicroRNAs and cardiovascular diseases |
| Q92541923 | MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities |
| Q37766210 | MicroRNAs in cardiovascular diseases: biology and potential clinical applications |
| Q34233643 | MicroRNAs overexpressed in growth-restricted rat skeletal muscles regulate the glucose transport in cell culture targeting central TGF-β factor SMAD4 |
| Q37744073 | MicroRNAs-Mediated Regulation of Skeletal Muscle GLUT4 Expression and Translocation in Insulin Resistance |
| Q37146727 | MicroRNAs: potential mediators and biomarkers of diabetic complications. |
| Q64234430 | Micromanaging aerobic respiration and glycolysis in cancer cells |
| Q52642353 | Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides. |
| Q92111280 | Multiple roles of KLF15 in the heart: Underlying mechanisms and therapeutic implications |
| Q35657666 | Murine cytomegalovirus encodes a miR-27 inhibitor disguised as a target |
| Q26752678 | New Molecular Insights of Insulin in Diabetic Cardiomyopathy |
| Q38284580 | Noncoding RNAs as epigenetic mediators of skeletal muscle regeneration |
| Q38885481 | Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming. |
| Q47763435 | Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy |
| Q37591526 | Prenatal stress changes the glycoprotein GPM6A gene expression and induces epigenetic changes in rat offspring brain |
| Q40479009 | Reciprocal repression between Fgf8 and miR-133 regulates cardiac induction through Bmp2 signaling |
| Q38026041 | Regulation of Aerobic Glycolysis by microRNAs in Cancer |
| Q28592957 | Regulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5 |
| Q28076454 | Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects |
| Q39192355 | Role of biomarkers in predicting diabetes complications with special reference to diabetic foot ulcers |
| Q34732584 | Role of miR-1 and miR-133a in myocardial ischemic postconditioning |
| Q37953896 | Role of microRNAs in diabetes and its cardiovascular complications. |
| Q36585153 | Roles of microRNA on cancer cell metabolism |
| Q26795757 | Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease |
| Q34485522 | Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology. |
| Q34777160 | Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis |
| Q36731493 | Tanshinol Rescues the Impaired Bone Formation Elicited by Glucocorticoid Involved in KLF15 Pathway. |
| Q52657176 | The Destiny of Glucose from a MicroRNA Perspective. |
| Q48042168 | The Effect of a High-Protein Diet and Exercise on Cardiac AQP7 and GLUT4 Gene Expression. |
| Q58707465 | The Melanocortin MC5R as a New Target for Treatment of High Glucose-Induced Hypertrophy of the Cardiac H9c2 Cells |
| Q61816712 | The diagnostic value of circulating microRNAs in heart failure |
| Q46488114 | The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis |
| Q36597976 | The programming of cardiac hypertrophy in the offspring by maternal obesity is associated with hyperinsulinemia, AKT, ERK, and mTOR activation |
| Q38272241 | Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells |
| Q55443461 | miR-133a function in the pathogenesis of dedifferentiated liposarcoma. |
| Q64997497 | miR-15a/-16 Inhibit Angiogenesis by Targeting the Tie2 Coding Sequence: Therapeutic Potential of a miR-15a/16 Decoy System in Limb Ischemia. |
| Q37376524 | miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth. |
| Q50064930 | miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming |
| Q37015090 | miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance |
| Q38061096 | miRNAs, polyphenols, and chronic disease |
| Q33728265 | microRNAs in heart disease: putative novel therapeutic targets? |
Search more.